An international study on starting tumour necrosis factor‐blocking agents in ankylosing spondylitis

OBJECTIVES: To determine the type and proportion of patients with ankylosing spondylitis who rheumatologists consider to be candidates for treatment with tumour necrosis factor (TNF)‐blocking agents, and to what extent this is in agreement with the ASsessment in Ankylosing Spondylitis (ASAS) interna...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pham, T, Landewé, R, van der Linden, S, Dougados, M, Sieper, J, Braun, J, Davis, J, Rudwaleit, M, Collantes, E, Burgos‐Vargas, R, Edmonds, J, Olivieri, I, van der Horst‐Bruinsma, I, Mielants, H, Stone, M, Emery, P, van der Heijde, D
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798475/
https://ncbi.nlm.nih.gov/pubmed/16464984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.042630
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars